Concepedia
Statistics
Publications
15
Citations
653
H-Index
14
Active since
2006
Affiliations
Eli Lilly (United States)(Current)
Amgen (United States)
Health Outcomes Solutions (United States)
Nicole Yurgin is an author at Eli Lilly (United States) specializing in diabetes mellitus, medicine, and pharmacy.
Publications per year
2006–2019
Utilities and disutilities for type 2 diabetes treatment-related attributes
Louis S. Matza, Kristina S. Boye, Nicole Yurgin et al. · Quality of Life Research · 2007 · 115 citations
Pharmacy, Pharmacoeconomics, Cost-utility Analysis +13
Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US
Anju Parthan, Morgan Kruse, Nicole Yurgin et al. · Applied Health Economics and Health Policy · 2013 · 80 citations
Pharmacy, Pharmacoeconomics, Bone Metabolism +15
Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: A retrospective database study
Nicole Yurgin, Kristina Secnik, Maureen J. Lage · Clinical Therapeutics · 2007 · 80 citations
Medicine, Endocrinology, Internal Medicine +13
Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
Louis S. Matza, Kristina S. Boye, Nicole Yurgin · Health and Quality of Life Outcomes · 2007 · 74 citations · Full text
Pharmacy, Psychology, Health Assessment +14
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes
Joshua Ray, Kristina S. Boye, Nicole Yurgin et al. · Current Medical Research and Opinion · 2007 · 56 citations · Full text
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
1–5 of 15